Alkem Laboratories Share Price

Alkem launches novel antibiotic combination for drug-resistant infections

Enzene Biosciences raises $50 million, aims to expand into global markets

Need a serious fall in Indian markets before I start buying

Nykaa Q3 FY25 results: Net profit rises 61% to Rs 26 crore, revenue up 27%

GIFT City spillover boosts Ahmedabad's rise as a trading hub, shows data

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that a conference call to discuss the Q3FY23 financial results will be held on Friday 10th February 2023 at 05.00 pm.Please find attached herewith the conference call details.Kindly take note of the same.

The record date for the purpose of payment of Interim Dividend for the financial year 2022-2023 would be Saturday 18th February 2023 subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 10th February 2023.Kindly take note of the same.

The record date for the purpose of payment of Interim Dividend for the financial year 2022-2023 would be Saturday 18th February 2023 subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 10th February 2023.Kindly take note of the same.

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2022; and (ii) Interim Dividend for the financial year 2022-2023. The record date for the purpose of payment of Interim Dividend for the financial year 2022-2023 would be Saturday 18th February 2023 subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 10th February 2023.

In continuation of our letter dated 06th December 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the resolution as proposed in the Postal Ballot Notice dated 11th November 2022 has been passed by the Members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizers Report. The same are also being uploaded on Companys website viz. https://www.alkemlabs.com/Postal-Ballot.php The approval is deemed to have been received on the last date of remote e-voting i.e. 05th January 2023.